NIH’s All of Us Partners with HudsonAlpha on Long-Read Sequencing Project
The NIH’s All of Us Research Program has chosen the HudsonAlpha Institute for Biotechnology to assess the use of DNA sequencing technologies for diagnosis and treatment of common and rare diseases, under a $7 million project to be funded...
Proper Prescribing: Pharmacogenetics Testing Gains Traction but Requires a Delicate Balancing Act
Pharmacogenomic testing is gaining traction, but incorporating it into the clinical setting with high fidelity requires a delicate balance.
Ending the Odyssey: Leveraging Improved Sequencing Technology, Rare Disease Diagnosis Speeds Up and Spreads Out
Leveraging improvements in sequencing technology that increase speed and lower costs, rare disease diagnostics broadens its reach.
Artificial Intelligence Enhances Oncology
The volume of information that needs to be analyzed to make precision medicine a reality in cancer care is often beyond the realm of the human mind. That’s where artificial intelligence steps in
PerkinElmer Genomics, U. of Iowa Develop FSHD Assay Based on Bionano’s Saphyr
Bionano Genomics announced at the American Society of Human Genetics (ASHG) annual meeting in Houston that PerkinElmer Genomics and the University of Iowa have both adopted use of Bionano’s Saphyr whole-genome imaging platform in their assay development labs, with PerkinElmer being the first to develop and validate an assay...
SOPHiA Genetics to Integrate Mastermind Genomic Search Engine
SOPHiA Genetics, a genomic health data company that leverages artificial intelligence to provide clinical and genomic insights, and genomic analysis company Genomenon announced Tuesday at the American Society of Human Genetics (ASHG) annual meeting the integration of Genomenon’s Mastermind Genomic Search Engine with the SOPHiA artificial intelligence platform and...
IVF Preimplantation Test for Aneuploidy
PerkinElmer has introduced the PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit, that tests spent embryo culture media for chromosomal abnormalities during in vitro fertilization (IVF) treatment. Traditionally, PGT-A requires an invasive biopsy of a developing embryo for the removal and testing of a few cells.
PerkinElmer’s PG-Seq...
Artificial Intelligence Enhances Oncology
The volume of information that needs to be analyzed to make precision medicine a reality in cancer care is often beyond the realm of the human mind. That’s where artificial intelligence steps in
Cleveland Clinic, Owlstone Medical Establish Center for Early Disease Detection
Cleveland Clinic said today it is partnering with Owlstone Medical to establish a new center focused on studying the detection of diseases ranging from chronic conditions to cancer by measuring volatile organic compounds (VOCs) in exhaled breath, in combination with other non-invasive biomarkers from other bodily fluids such as...
Exact Sciences, Mayo Clinic Partner on Colorectal Cancer Screening Study
Exact Sciences said it is partnering with Mayo Clinic to launch a study designed to assess more than 150,000 people who have ordered the company’s marketed Cologuard test for colorectal cancer, and follow them for at least seven years to evaluate clinical outcomes.
The Voyage study (NCT04124406) is designed to...
Color, Verily to Return Actionable Genetic Data to Project Baseline Participants
Color and Verily Life Sciences said they will partner to return actionable genetic information to all participants in the Project Baseline Health Study, Verily’s four-year initiative to collect comprehensive health information to better understand health and the transition to disease.
Project Baseline Health Study participants will have access to Color’s...
Genetic Differences in Immune System Influences Makeup of Microbiome
Scientists headed by a team at the University of Chicago have shown how genetic differences in the immune system can impact on the types of bacterial communities that colonize the gastrointestinal system. Their studies, in germ-free mice colonized with microbiomes from conventionally reared animals, found that while the makeup...
Third “Short Sleep” Gene Discovered Prevents Memory Deficits
Although it is recommended for most people to get 7 to 9 hours of sleep, there are some people who can sleep for just 4 to 6 hours and feel well-rested. The team that identified two known human genes that promote this “natural short sleep” have now discovered a...
BCH N of 1 Trial Yields Approved Therapy for Single Rare Disease Patient
The promise of precision medicine is focused on providing the right drug to the right patient at the right time. Usually that means matching patients, based on their molecular profiles to specific approved drugs. But precision medicine has never created a unique drug intended to treat one—and only one—patient.
Until...
![Berg will partner with Massachusetts General Hospital and Brigham and Women's Hospital to study potential biomarkers for Alzheimer's and other neurodegenerative disorders from Harvard Biomarker Study biospecimens. [Source: ajcity.net]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1397-324x160.jpeg "NIA Invests $73 Million in New Alzheimer’s Research Centers")
![Verge Genomics has raised $32 million in Series A financing toward further development of new treatments by combining machine learning and neuroscience with experimental biology. [Source: kentoh/Getty Images]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1787-324x160.jpeg "Novartis, with Assist from Microsoft, Launches AI Innovation Lab")
